These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 4960742)

  • 1. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.
    Dias Da Silva W; Lepow IH
    J Exp Med; 1967 May; 125(5):921-46. PubMed ID: 4960742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
    da Silva WD; Eisele JW; Lepow IH
    J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
    Cochrane CG; Müller-Eberhard HJ
    J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylatoxin formation by purified human C'1 esterase.
    Dias da Silva W; Lepow IH
    J Immunol; 1965 Dec; 95(6):1080-9. PubMed ID: 4158798
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin.
    Austen KF; Becker EL
    J Exp Med; 1966 Sep; 124(3):397-416. PubMed ID: 4162486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE ROLE OF THE COMPONENTS OF COMPLEMENT IN SPECIFIC IMMUNE FIXATION.
    Pillemer L; Seifter S; Ecker EE
    J Exp Med; 1942 Apr; 75(4):421-35. PubMed ID: 19871194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.
    RATNOFF OD; LEPOW IH
    J Exp Med; 1963 Nov; 118(5):681-98. PubMed ID: 14087615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific inactivator of mammalian C'4 isolated from nurse shark (Ginglymostoma cirratum) serum.
    Jensen JA
    J Exp Med; 1969 Aug; 130(2):217-41. PubMed ID: 4893886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    Müller-Eberhard HJ; Polley MJ; Calcott MA
    J Exp Med; 1967 Feb; 125(2):359-80. PubMed ID: 6019133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE.
    Hinz CF; Picken ME; Lepow IH
    J Exp Med; 1961 Jan; 113(1):193-218. PubMed ID: 19867184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
    Hugli TE; Erickson BW
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conversion of C'IS to C'1 esterase by plasmin and trypsin.
    Ratnoff OD; Naff GB
    J Exp Med; 1967 Feb; 125(2):337-58. PubMed ID: 4225264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.
    Polley MJ; Müller-Eberhard HJ
    J Exp Med; 1968 Sep; 128(3):533-51. PubMed ID: 5666963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on immune cellular injury. II. Functional role of C'1 esterase in immune cytotoxicity.
    LEPOW IH; ROSS A
    J Exp Med; 1960 Dec; 112(6):1107-20. PubMed ID: 13761024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
    Stimler-Gerard NP; Galli SJ
    J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the antigenic properties of complement. II. Analysis of specific agglutinins against certain components of guinea pig complement fixed on sensitized sheep erythrocytes.
    KLEIN PG; BURKHOLDER PM
    J Exp Med; 1960 Jan; 111(1):107-17. PubMed ID: 14409703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    Fukuoka Y; Hugli TE
    J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylatoxin release from the third component of human complement by hydroxylamine.
    Budzko DB; Müller-Eberhard H
    Science; 1969 Aug; 165(3892):506-7. PubMed ID: 5815704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FUNCTION OF COMPONENTS OF COMPLEMENT IN IMMUNE HEMOLYSIS.
    Pillemer L; Seifter S; Chu F; Ecker EE
    J Exp Med; 1942 Jul; 76(1):93-101. PubMed ID: 19871223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.
    Gigli I; Nelson RA
    Exp Cell Res; 1968 Jul; 51(1):45-67. PubMed ID: 5661952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.